AtriCure (ATRC) Interest & Investment Income (2010 - 2026)
AtriCure (ATRC) reported Interest & Investment Income of $1.2 million for Q1 2026, up 19.48% year-over-year from $1.0 million in Q1 2025, and down 6.46% quarter-over-quarter from $1.3 million in Q4 2025.
AtriCure (ATRC) Interest & Investment Income (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has 17 years of Interest & Investment Income data on file, last reported at $1.2 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $1.2 million, up 19.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.7 million (up 3.49% YoY), and the FY2025 annual result was $4.5 million, up 1.01% from the prior year.
- Interest & Investment Income declined to $1.2 million in Q1 2026 per ATRC's latest filing, from $1.3 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.4 million in Q4 2022 and troughed at $76000.0 in Q2 2022.
- A 5-year average of $937882.4 and a median of $997000.0 in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income surged 1178.57% in 2022, then declined 27.3% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $1.4 million in 2022, then decreased by 27.3% to $1.0 million in 2023, then climbed by 15.66% to $1.2 million in 2024, then increased by 10.55% to $1.3 million in 2025, then retreated by 6.46% to $1.2 million in 2026.
- Business Quant data shows ATRC's Interest & Investment Income at $1.2 million in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | AtriCure | 1.34 Bn | 1.19 Bn | 109.31 Mn | 1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 941,000.00 |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 997,000.00 |
| Mar 31, 2024 | 952,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 915,000.00 |
| Jun 30, 2023 | 961,000.00 |
| Mar 31, 2023 | 875,000.00 |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 370,000.00 |
| Jun 30, 2022 | 76,000.00 |
| Mar 31, 2022 | 116,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 117,000.00 |
| Jun 30, 2021 | 103,000.00 |